In our clinical experience, many patients are not sure of their diabetes type and, in the absence of blood tests (i.e., insulin autoantibodies, c-peptide), providers cannot always be entirely certain of diabetes type among patients treated only with insulin. This evidence concerns the gene INS and diabetes mellitus.